We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

201 hedge funds and large institutions have $917M invested in Editas Medicine in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 65 increasing their positions, 46 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

41% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 46

29% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 28

18% more capital invested

Capital invested by funds: $780M → $917M (+$137M)

4.25% more ownership

Funds ownership: 72.11% → 76.36% (+4.3%)

4% more funds holding

Funds holding: 194 → 201 (+7)

73% less call options, than puts

Call options by funds: $7.03M | Put options by funds: $26.5M

Holders
201
Holders Change
+7
Holders Change %
+3.61%
% of All Funds
4.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
36
Increased
65
Reduced
46
Closed
28
Calls
$7.03M
Puts
$26.5M
Net Calls
-$19.5M
Net Calls Change
-$21.6M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$34.7M
2
NAMA
Nikko Asset Management Americas
New York
+$16.7M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$16.3M
4
State Street
State Street
Massachusetts
+$15.9M
5
GLA
Great Lakes Advisors
Illinois
+$6.25M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.37M
3
JCM
JS Capital Management
New York
-$4.98M
4
UBS AM
UBS AM
Illinois
-$3.8M
5
Capital International Investors
Capital International Investors
California
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$9.08M +$2.25M +99,400 +37%
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$7.04M -$5.37M -237,063 -45%
GLA
28
Great Lakes Advisors
Illinois
$6.75M +$6.25M +276,195 New
TA
29
Teachers Advisors
New York
$6.73M +$23.4K +1,035 +0.4%
SBH
30
Segall Bryant & Hamill
Illinois
$6.62M +$6.13M +270,950 New
Charles Schwab
31
Charles Schwab
California
$6.21M +$258K +11,392 +5%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$5.38M +$444K +19,605 +10%
WCM
33
Wildcat Capital Management
New York
$4.54M – – –
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$4.3M -$3.32M -146,476 -45%
Bank of America
35
Bank of America
North Carolina
$4.21M +$3.09M +136,529 +384%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$3.45M +$3.19M +140,921 New
UBS Group
37
UBS Group
Switzerland
$3.14M +$649K +28,664 +29%
Millennium Management
38
Millennium Management
New York
$3.09M +$1.2M +53,223 +73%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$2.74M +$127K +5,600 +5%
SAMH
40
Shanda Asset Management Holdings
British Virgin Islands
$2.53M +$1.13M +50,000 +93%
3C
41
361 Capital
Colorado
$2.49M +$216K +9,564 +10%
Squarepoint
42
Squarepoint
New York
$2.36M +$276K +12,181 +14%
TCIM
43
TIAA CREF Investment Management
New York
$1.97M -$1.66M -73,464 -48%
PPA
44
Parametric Portfolio Associates
Washington
$1.88M +$775K +34,229 +80%
TCM
45
Tekla Capital Management
Massachusetts
$1.88M – – –
EWM
46
Elmwood Wealth Management
California
$1.74M -$207K -9,124 -11%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.73M -$35.6K -1,574 -2%
Nisa Investment Advisors
48
Nisa Investment Advisors
Missouri
$1.73M – – –
Man Group
49
Man Group
United Kingdom
$1.72M +$1.59M +70,320 New
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$1.66M +$471K +20,800 +44%
1
2
3 4 5

EDIT Hedge Fund Activity: Q1 2019 in Review

201 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2019, worth a combined $917M — up 18% from $780M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new EDIT positions and 28 closed out — a net gain of 8 holders — while 65 added to existing stakes and 46 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $34.7M. The largest seller was Fidelity Investments, cutting an estimated $11.5M.

  • 201 institutional investors held Editas Medicine (EDIT) as of Q1 2019, up from 194 in Q4 2018.
  • Funds reported $917M of Editas Medicine stock for Q1 2019, up 18% quarter-over-quarter.
  • 36 funds opened new Editas Medicine positions in Q1 2019 and 28 closed out, a net change of +8 holders.
  • The largest Editas Medicine buyer in Q1 2019 was ARK Investment Management, an estimated $34.7M added.
  • The largest Editas Medicine seller in Q1 2019 was Fidelity Investments, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2019.